Replies to post #35596 on Biotech Values

[DewDiligence]

NTMD humor from the ymb in reference to
the company’s patent threats against HMOs
who recommend generics in place of BiDil:

>>
I am today patenting a new formulation -- the two component generic pills scotch-taped together. Only charging 150% the "plain" generics price!
<<

Surprising that NTMD is up sharply today based on a WSJ article (#msg-14034161) I would hardly describe as bullish.

[DewDiligence]

NTMD BiDil revenue in 3Q06 was… $3.4M.
That’s about $50K per selling day, less than
$1,000 per sales rep per selling day more than
a year since the product launch. Pathetic.

http://biz.yahoo.com/bw/061102/20061102005982.html?.v=1